Psychedelic Harm Reduction and Exploration Group (New York, NY)

Psychedelic Harm Reduction and Exploration Group

Organizers: Elizabeth Nielson, PhD and Ingmar Gorman, PhD

Date & Time: Mondays, 5:45 – 7:00 pm

In person location: 370 Lexington Avenue, Suite 500, New York, NY 10017

Website: www.psychedelicprogram.com

The Psychedelic Harm Reduction and Exploration Group is a psychotherapy group for people who have used psychedelics, or are considering using them, for therapeutic and/or recreational purposes. Given that psychedelics are being tested in clinical trials but are not FDA approved for any indication at this time, this group is for people who wish to explore their own individual and unique relationship to psychedelics including the relative safety and potential helpfulness or harmfulness of using psychedelics, strategies for promoting positive experiences, and minimizing the possibility of negative consequences should they decide to do so on their own. Principles of psychedelic-assisted psychotherapy are incorporated into a group process in which participants can explore motivations, intentions, and outcomes of psychedelic use in a safe, supportive environment. Group discussions focus on integrating the profound insights, lessons, and even difficult experiences of psychedelic journeys into one’s broader life. Members are expected to attend this group weekly.

This group requires a commitment to weekly participation. The size of this group is limited due to the nature of the therapeutic process that is engaged in.

About the Organizers

Dr. Elizabeth Nielson is a clinical psychologist with a holistic, compassionate, and integrative approach to psychotherapy. She specializes in treating addictive and mood disorders with a blend of of mindfulness-based interventions, dialectical behavior therapy, psychodynamic therapy, community reinforcement and family training (CRAFT), and principles of psychedelic-assisted therapy. Dr. Nielson’s work is guided by the idea that each individual has within them the capacity for growth and change, and sets out to support the natural healing process by building awareness, autonomy, and self-compassion. Dr. Nielson is part of the Experimental Therapeutics Research Laboratory at NYU Langone School of Medicine where she is a therapist on the psilocybin-assisted treatment for alcohol dependence trial and on the MDMA-assisted psychotherapy for PTSD clinical trials. Ingmar Gorman, Ph.D., is a clinical psychologist who specializes in assisting populations who have had experiences with psychedelics and other psychoactive compounds. He is the Director of the Psychedelic Education and Continuing Care Program, where he leads groups, trainings, and works with individual clients. Dr. Gorman is also site co-principal Investigator and therapist on a Phase 3 clinical trial studying the potential psychotherapeutic utility of MDMA for post-traumatic stress disorder. He is a NIH funded fellow at New York University and a board member of Horizons Media, Inc., a not for-profit educational charity and organizer of the Horizons Conference: Perspectives on Psychedelics.

Location

New York City, New York

Send a message to this provider. Please do not ask for anything illegal. For more information Read our Terms of Service and FAQ.

Interests

characters remaining

Your message will go directly to this provider and does not opt-in for the email newsletter.